EMI (Encore Medical) Other Stockholders Equity: $-0.00 Mil (As of Dec. 2025)


What is Encore Medical Other Stockholders Equity?

Encore Medical EMI Other Stockholders Equity is $-0.00 Mil as of Dec. 2025.

Encore Medical's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $-0.00 Mil.

Encore Medical's quarterly Other Stockholders Equity increased from Jun. 2025 ($-0.00 Mil) to Sep. 2025 ($-0.00 Mil) but then stayed the same from Sep. 2025 ($-0.00 Mil) to Dec. 2025 ($-0.00 Mil).

Encore Medical's annual Other Stockholders Equity increased from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($0.00 Mil) but then declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

Encore Medical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Encore Medical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Other Stockholders Equity Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Other Stockholders Equity
-0.00 0.00 -0.00

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial 0.00 0.00 -0.00 -0.00 -0.00

Encore Medical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Encore Medical (EMI) has a Other Stockholders Equity of $-0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Encore Medical and its competitors.
Is Encore Medical's Other Stockholders Equity too high?
Encore Medical's current Other Stockholders Equity is $-0.00 Mil.
How does Encore Medical's Other Stockholders Equity compare to ?
Encore Medical's Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Encore Medical and its competitors. Encore Medical's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Encore Medical (EMI), the current Other Stockholders Equity is $-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).